An Update on the Multifaceted Roles of STAT3 in the Heart
- PMID: 31709266
- PMCID: PMC6823716
- DOI: 10.3389/fcvm.2019.00150
An Update on the Multifaceted Roles of STAT3 in the Heart
Abstract
Signal transducer and activator of transcription 3 (STAT3) is a signaling molecule and transcription factor that plays important protective roles in the heart. The protection mediated by STAT3 is attributed to its genomic actions as a transcription factor and other non-genomic roles targeting mitochondrial function and autophagy. As a transcription factor, STAT3 upregulates genes that are anti-oxidative, anti-apoptotic, and pro-angiogenic, but suppresses anti-inflammatory and anti-fibrotic genes. Its suppressive effects on gene expression are achieved through competing with other transcription factors or cofactors. STAT3 is also linked to the modification of mRNA expression profiles in cardiac cells by inhibiting or inducing miRNA. In addition to these genomic roles, STAT3 is suggested to function protectively in mitochondria, where it regulates ROS production, in part by regulating the activities of the electron transport chain complexes, although our recent evidence calls this role into question. Nonetheless, STAT3 is a key player known to be activated in the cardioprotective ischemic conditioning protocols. Through these varied roles, STAT3 participates in various mechanisms that contribute to cardioprotection against different heart pathologies, including myocardial infarction, hypertrophy, diabetic cardiomyopathy, and peripartum cardiomyopathy. Understanding how STAT3 is involved in the protective mechanisms against these different cardiac pathologies could lead to novel therapeutic strategies to treat them.
Keywords: STAT3; cardiac pathologies; cardioprotection; genomic functions; myocardial infarction.
Copyright © 2019 Harhous, Booz, Ovize, Bidaux and Kurdi.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/6823716/bin/fcvm-06-00150-g0001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/6823716/bin/fcvm-06-00150-g0002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/6823716/bin/fcvm-06-00150-g0003.gif)
Similar articles
-
Perspective: mitochondrial STAT3 in cardioprotection.Basic Res Cardiol. 2023 Aug 24;118(1):32. doi: 10.1007/s00395-023-01003-3. Basic Res Cardiol. 2023. PMID: 37620559 Free PMC article. Review.
-
The crosstalk between STAT3 and microRNA in cardiac diseases and protection.Front Cardiovasc Med. 2022 Sep 6;9:986423. doi: 10.3389/fcvm.2022.986423. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36148063 Free PMC article. Review.
-
Regulation of STAT3 and its role in cardioprotection by conditioning: focus on non-genomic roles targeting mitochondrial function.Basic Res Cardiol. 2021 Oct 12;116(1):56. doi: 10.1007/s00395-021-00898-0. Basic Res Cardiol. 2021. PMID: 34642818 Free PMC article. Review.
-
Pivotal Importance of STAT3 in Protecting the Heart from Acute and Chronic Stress: New Advancement and Unresolved Issues.Front Cardiovasc Med. 2015 Nov 30;2:36. doi: 10.3389/fcvm.2015.00036. eCollection 2015. Front Cardiovasc Med. 2015. PMID: 26664907 Free PMC article. Review.
-
Cardioprotective function of mitochondrial-targeted and transcriptionally inactive STAT3 against ischemia and reperfusion injury.Basic Res Cardiol. 2015 Nov;110(6):53. doi: 10.1007/s00395-015-0509-2. Epub 2015 Sep 11. Basic Res Cardiol. 2015. PMID: 26358226
Cited by
-
The Role of the JAK-STAT Signaling Pathway in the Protective Effects of Hepatic Ischemia Post-conditioning Against the Injury Induced by Ischemia/Reperfusion in the Rat Liver.Adv Pharm Bull. 2024 Mar;14(1):224-230. doi: 10.34172/apb.2024.003. Epub 2023 Jul 19. Adv Pharm Bull. 2024. PMID: 38585457 Free PMC article.
-
A bioinformatics approach to elucidate conserved genes and pathways in C. elegans as an animal model for cardiovascular research.Sci Rep. 2024 Mar 29;14(1):7471. doi: 10.1038/s41598-024-56562-9. Sci Rep. 2024. PMID: 38553458 Free PMC article.
-
JAK/STAT3 signaling in cardiac fibrosis: a promising therapeutic target.Front Pharmacol. 2024 Mar 1;15:1336102. doi: 10.3389/fphar.2024.1336102. eCollection 2024. Front Pharmacol. 2024. PMID: 38495094 Free PMC article. Review.
-
Immunotherapy targeting the obese white adipose tissue microenvironment: Focus on non-communicable diseases.Bioact Mater. 2024 Feb 19;35:461-476. doi: 10.1016/j.bioactmat.2024.01.027. eCollection 2024 May. Bioact Mater. 2024. PMID: 38404641 Free PMC article.
-
Protein-protein interaction network-based integration of GWAS and functional data for blood pressure regulation analysis.Hum Genomics. 2024 Feb 8;18(1):15. doi: 10.1186/s40246-023-00565-6. Hum Genomics. 2024. PMID: 38326862
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous